Drug Type Chemical drugs |
Synonyms- |
Target |
Action agonists |
Mechanism KCNQ (Kv7) agonists(KCNQ (Kv7) potassium channel agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Amyotrophic Lateral Sclerosis | Preclinical | United States | 07 May 2021 | |
| Dystonic Disorders | Preclinical | United States | 07 May 2021 | |
| Epilepsy | Preclinical | United States | 07 May 2021 | |
| Pain | Preclinical | United States | 07 May 2021 | |
| Tinnitus | Preclinical | United States | 07 May 2021 |





